Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women

J Endocrinol Invest. 2014 Aug;37(8):739-744. doi: 10.1007/s40618-014-0101-x. Epub 2014 Jun 7.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of type 2 diabetes mellitus (T2DM). Insulin resistance and beta-cell dysfunction are involved in the pathogenesis of T2DM. Insulin resistance is associated with NAFLD but little is known about beta-cell dysfunction and NAFLD.

Aim: We tested whether NAFLD severity is associated with insulin sensitivity and beta-cell function in morbidly obese women.

Subjects and methods: We studied 61 Caucasian women aged 18-60 years without T2DM and with a body mass index ranging from 35.3 to 48.8 kg/m². The insulin sensitivity index (ISI) and the disposition index (DI) from oral glucose tolerance testing were used as measures of insulin sensitivity and beta-cell function, respectively. Fat was measured by dual-energy X-ray absorptiometry. Fatty liver was diagnosed by ultrasonography and ordinally coded as 0 = none, 1 = light, 2 = moderate, 3 = severe. Proportional-odds logistic regression was used to evaluate the association of NAFLD severity with log(e)ISI and log(e)DI with and without correction for total and truncal fat.

Results: The odds of more severe vs. less severe NAFLD decreased for increasing log(e)ISI [odds ratio (OR) 0.40, 95 % CI 0.19-0.84, p < 0.05] and log(e)DI (OR 0.80, 95 % CI 0.69-0.92, p < 0.01). Neither total nor truncal fat had any effect on these associations.

Conclusion: In morbidly obese women, NAFLD severity is inversely associated with insulin sensitivity and beta-cell function. The association of NAFLD severity with beta-cell dysfunction is stronger than that with insulin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Fat / diagnostic imaging
  • Absorptiometry, Photon
  • Adiposity
  • Adolescent
  • Adult
  • Body Mass Index
  • Female
  • Glucose Tolerance Test
  • Humans
  • Insulin / metabolism*
  • Insulin Resistance*
  • Insulin Secretion
  • Insulin-Secreting Cells / metabolism*
  • Italy
  • Liver / diagnostic imaging
  • Logistic Models
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / diagnostic imaging
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Obesity, Morbid / physiopathology*
  • Severity of Illness Index
  • Ultrasonography
  • Young Adult

Substances

  • Insulin